BPIFC: Key Regulator of Cellular Stress Response and Neurodegenerative Diseases

Target Name: BPIFC

NCBI ID: G254240

BPIFC

BPIFC: Key Regulator of Cellular Stress Response and Neurodegenerative Diseases

BPIFC (Brain-Peroxisome-Initiator-F domain) is a protein that is expressed in various tissues of the body, including the brain. It is a key regulator of the cellular stress response, and has been implicated in a number of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases.

BPIFC is composed of a series of transmembrane domains that give it its unique structure and function. These domains include a N-terminus that is involved in the formation of the protein complex that it functions in, a M-terminus that is responsible for the interaction with other proteins, and a H-terminal region that contains a domain similar to a peroxisome-associated protein (PAP) domain.

The BPIFC protein is involved in a number of cellular processes that are critical for the survival and proper functioning of cells. One of its key functions is to regulate the cellular stress response, which is a critical element of the cell's ability to respond to environmental stimuli and maintain its integrity.

BPIFC is also involved in the regulation of cell signaling pathways that are important for the development and progression of many diseases, including neurodegenerative diseases. For example, studies have shown that BPIFC is involved in the regulation of the tau protein, which is a key component of the neurotransmitter dopamine and is implicated in the development of Parkinson's disease.

In addition to its role in the cellular stress response and the regulation of cell signaling pathways, BPIFC has also been shown to play a role in the development and progression of neurodegenerative diseases. For example, studies have shown that BPIFC is involved in the regulation of the aggregation of beta-amyloid peptides, which are a hallmark of Alzheimer's disease.

BPIFC is also a potential drug target in the treatment of neurodegenerative diseases. Studies have shown that blocking the activity of BPIFC using small interfering RNA (siRNA) can significantly improve the survival of mouse models of Alzheimer's disease. Additionally, inhibiting the activity of BPIFC using a similar approach has also been shown to improve the survival of human samples of neurodegenerative diseases.

BPIFC is also a potential biomarker for the diagnosis and prognosis of neurodegenerative diseases. For example, studies have shown that the level of BPIFC is significantly decreased in the brains of individuals with Alzheimer's disease, and that this decrease is associated with the severity of the disease . Similarly, levels of BPIFC have also been shown to be decreased in the brains of individuals with Parkinson's disease, and this decrease is also associated with the severity of the disease.

In conclusion, BPIFC is a protein that is involved in a number of cellular processes that are critical for the survival and proper functioning of cells. It is also involved in the regulation of the cellular stress response and the development and progression of neurodegenerative diseases. Additionally , BPIFC is a potential drug target and biomarker for the treatment of these diseases. Further research is needed to fully understand the role of BPIFC in these processes and to develop effective treatments.

Protein Name: BPI Fold Containing Family C

The "BPIFC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BPIFC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets